Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution

Table 1 Bile production in liver of each group at different time points (n = 4, mean ± SD)

Group	Bile production in liver (mL)
	1 h	2 h	3 h	4 h
A	1.75 ± 0.29	2.25 ± 0.29	3.88 ± 0.25	5.25 ± 0.29
B	2.62 ± 0.25b	4.63 ± 0.48b	6.00 ± 0.41b	6.63 ± 0.25b

^bP < 0.01 vs group A.

Table 2 Pressure of hepatic artery and portal vein in each group at different time points (n = 4, mean ± SD)

Group	Pressure of hepatic artery (mmHg)				Pressure of portal vein (mmHg)
	1 h	2 h	3 h	4 h	1 h	2 h	3 h	4 h
A	101.13 ± 1.65	98.75 ± 1.94	93.75 ± 1.19	90.50 ± 1.58	8.25 ± 0.65	7.50 ± 0.41	7.00 ± 0.41	6.63 ± 0.25
B	97.75 ± 1.44a	94.50 ± 1.08a	91.25 ± 1.04b	89.88 ± 1.11	7.50 ± 0.41a	7.13 ± 0.48	6.75 ± 0.29	6.50 ± 0.41

^aP < 0.05,

^bP < 0.01 vs group A.

Table 3 Level of ALT and LDH in perfusate of each group at different time points (n = 4, mean ± SD)

Group	Level of ALT (U/L)				Level of LDH (U/L)
	1 h	2 h	3 h	4 h	1 h	2 h	3 h	4 h
A	62.50 ± 4.20	80.75 ± 5.62	96.75 ± 4.57	115.50 ± 6.25	619.50 ± 19.54	787.00 ± 23.35	897.25 ± 17.78	974.25 ± 27.32
B	38.50 ± 2.89b	42.50 ± 2.89b	46.35 ± 3.30b	53.25 ± 2.63b	442.00 ± 19.58b	535.00 ± 20.43b	629.50 ± 45.89b	687.25 ± 25.94b

^bP < 0.01 vs group A.

Table 4 Level of glucose in perfusate and oxygen consumption in livers of each group at different time points (n = 4, mean ± SD)

Group	Level of glucose in perfusate (mmol/L)				Oxygen consumption in livers
	1 h	2 h	3 h	4 h	1 h	2 h	3 h	4 h
A	619.50 ± 19.54	787.00 ± 23.35	897.25 ± 17.78	974.25 ± 27.32	269.50 ± 12.45	234.50 ± 13.48	216.00 ± 7.75	192.25 ± 8.50
B	442.00 ± 19.58b	535.00 ± 20.43b	629.50 ± 45.89b	687.25 ± 25.94b	244.00 ± 8.44b	267.00 ± 7.07a	258.00 ± 4.97	251.25 ± 5.74

^aP < 0.05,

^bP < 0.01 vs group A.